 3. Planned administration or administration of a vaccineproduct not planned in the study protocol during the period starting 30 days prior to the first dose of vaccineplacebo until 30 days after the last dose of study vaccineplacebo routine influenza vaccination will be allowed as long as it is not administered within 14 days of the vaccineplacebo, and will not lead to study exclusion although it should be reported to the PI 